LifeSci Capital Initiates Coverage On Protara Therapeutics with Outperform Rating, Announces Price Target of $22

Benzinga · 4d ago
LifeSci Capital initiates coverage on Protara Therapeutics (NASDAQ:TARA) with a Outperform rating and announces Price Target of $22.